Cargando…

TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network

The thioredoxin domain containing proteins are a group of proteins involved in redox regulation and have been recently reported to be associated with tumor progression. However, the role of thioredoxin proteins in hepatocellular carcinoma (HCC) remains largely unknown. Here in our study, we demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Dawei, Zou, Jixue, Zhao, Zhenguo, Tang, Xiaodong, Deng, Zhicheng, Jia, Jingchao, Liu, Shuanghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208382/ https://www.ncbi.nlm.nih.gov/pubmed/30382079 http://dx.doi.org/10.1038/s41419-018-1150-4

Ejemplares similares

PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3
por: Chen, Dawei, et al.
Publicado: (2021)

TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG
por: Wang, Jing, et al.
Publicado: (2022)

Txndc9 Is Required for Meiotic Maturation of Mouse Oocytes
por: Ma, Fanhua, et al.
Publicado: (2017)

TXNDC12 inhibits lipid peroxidation and ferroptosis
por: Tang, Lanlan, et al.
Publicado: (2023)

Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation
por: Chan, Mikko C., et al.
Publicado: (2021)

The role and mechanism of TXNDC5 in diseases
por: Wang, Xueling, et al.
Publicado: (2022)

Circ_0000517 Contributes to Hepatocellular Carcinoma Progression by Upregulating TXNDC5 via Sponging miR-1296-5p
por: Zang, Hongliang, et al.
Publicado: (2020)

TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin
por: Yuan, Kefei, et al.
Publicado: (2019)

Investigate Pathogenic Mechanism of TXNDC5 in Rheumatoid Arthritis
por: Wang, Lin, et al.
Publicado: (2013)

Knockdown of TXNDC9 induces apoptosis and autophagy in glioma and mediates cell differentiation by p53 activation
por: Zheng, Tingting, et al.
Publicado: (2020)

Investigating a pathogenic role for TXNDC5 in rheumatoid arthritis
por: Chang, Xiaotian, et al.
Publicado: (2011)

High expression of TXNDC11 indicated unfavorable prognosis of glioma
por: Peng, Peng, et al.
Publicado: (2021)

CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
por: Huang, Chun-Hao, et al.
Publicado: (2014)

Role of TXNDC5 in tumorigenesis of colorectal cancer cells: In vivo and in vitro evidence
por: Tan, Fengbo, et al.
Publicado: (2018)

Targeting mechanosensitive endothelial TXNDC5 to stabilize eNOS and reduce atherosclerosis in vivo
por: Yeh, Chih-Fan, et al.
Publicado: (2022)

m(6)A Methyltransferase METTL3 Promotes the Progression of Primary Acral Melanoma via Mediating TXNDC5 Methylation
por: Yue, Zhanghui, et al.
Publicado: (2022)

TXNDC2 joint molecular marker is associated with testis pathology and is an accurate predictor of sperm retrieval
por: Javadirad, Seyed-Morteza, et al.
Publicado: (2021)

TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma
por: Yu, Hao, et al.
Publicado: (2023)

Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription
por: Xiao, Yao, et al.
Publicado: (2021)

Human circular RNA hsa_circRNA_101705 (circTXNDC11) regulates renal cancer progression by regulating MAPK/ERK pathway
por: Yang, Chong-Yi, et al.
Publicado: (2021)

TXNDC5, a Newly Discovered Disulfide Isomerase with a Key Role in Cell Physiology and Pathology
por: Horna-Terrón, Elena, et al.
Publicado: (2014)

Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma
por: Wang, Xinzhuang, et al.
Publicado: (2021)

The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications
por: Hung, Chen-Ting, et al.
Publicado: (2022)

A critical role of the thioredoxin domain containing protein 5 (TXNDC5) in redox homeostasis and cancer development
por: Chawsheen, Hedy A., et al.
Publicado: (2018)

FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC
por: Kim, Kyoung Min, et al.
Publicado: (2017)

A prenatally diagnosed case of Meckel–Gruber syndrome with novel compound heterozygous pathogenic variants in the TXNDC15 gene
por: Ridnõi, Konstantin, et al.
Publicado: (2019)

EDEM2 stably disulfide-bonded to TXNDC11 catalyzes the first mannose trimming step in mammalian glycoprotein ERAD
por: George, Ginto, et al.
Publicado: (2020)

Antibiotic Alleviates Radiation-Induced Intestinal Injury by Remodeling Microbiota, Reducing Inflammation, and Inhibiting Fibrosis
por: Zhao, Zhenguo, et al.
Publicado: (2020)

Menin enhances c-Myc-mediated transcription to promote cancer progression
por: Wu, Gongwei, et al.
Publicado: (2017)

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma
por: Guo, Xiaodong, et al.
Publicado: (2012)

Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma
por: Chen, Demeng, et al.
Publicado: (2018)

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
por: Borgenvik, Anna, et al.
Publicado: (2022)

TIMELESS contributes to the progression of breast cancer through activation of MYC
por: Chi, Limin, et al.
Publicado: (2017)

Enhanced photoelectrochemical aptasensing platform for TXNDC5 gene based on exciton energy transfer between NCQDs and TiO(2) nanorods
por: Pang, Xuehui, et al.
Publicado: (2016)

ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis
por: Chen, Junru, et al.
Publicado: (2020)

Association of single-nucleotide polymorphisms in RHOB and TXNDC3 with knee osteoarthritis susceptibility: two case-control studies in East Asian populations and a meta-analysis
por: Shi, Dongquan, et al.
Publicado: (2008)

WD repeat domain 48 promotes hepatocellular carcinoma progression by stabilizing c‐Myc
por: Li, Bo, et al.
Publicado: (2022)

Dissecting transcriptional amplification by MYC
por: Nie, Zuqin, et al.
Publicado: (2020)

Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients
por: Zou, Jixue, et al.
Publicado: (2022)

Heat Shock Protein 90α–Dependent B‐Cell‐2–Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto‐Oncogene c‐MYC mRNA Stability
por: Zhou, Xueqiong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6emcr5jrbmb12049phampf9f0b